• Robert Jordan has been appointed executive vice president of eCardio Diagnostics (The Woodlands, Texas), a provider of advanced technology cardiac arrhythmia monitoring. Most recently, Jordan served as an executive with Diagnostic Monitoring Associates.

• Michael Steele has joined Corautus Genetics (Atlanta) as vice president of business development, and will serve as a corporate officer. Steele most recently served as corporate vice president of Life Therapeutics. Corautus Genetics is a clinical-stage biopharmaceutical company developing gene transfer therapy products for the treatment of cardiovascular and peripheral vascular disease.

• David Fronk has been promoted from vice president of clinical research to vice president, regulatory affairs and quality assurance, for CryoLife (Kennesaw, Georgia). Fronk replaces Dr. Thomas Lynch, who has accepted a position with another company. CryoLife is a leader in the processing of implantable living human tissues for use in cardiovascular and vascular surgeries throughout the U.S. and Canada.

• Matthew Colbert has been appointed vice president of finance for Lifestream Technologies (Post Falls, Idaho), a supplier of cholesterol monitors. Colbert has been with Lifestream for more than five years, most recently as controller. He also has been appointed interim chief accounting and financial officer.

• Possis Medical (Minneapolis) reported that Jules Fisher has been appointed vice president of finance and chief financial officer and that Shawn McCarrey has been promoted to a new post as the company’s vice president of worldwide sales and marketing, as well as retaining sales responsibilities. Eapen Chacko has resigned as vice president and CFO and is leaving Possis to pursue other interests. Fisher formerly served as CFO of Minntech and has held senior financial positions with companies such as American Medical Systems, MedicalCV and U.S. Surgical. Possis manufactures devices for the cardiovascular and vascular treatment markets.